医学
回廊的
抗血栓
2019年冠状病毒病(COVID-19)
重症监护医学
静脉血栓栓塞
门诊护理
临床试验
梅德林
疾病管理
疾病
医疗保健
医疗急救
急诊医学
血栓形成
外科
传染病(医学专业)
内科学
帕金森病
经济增长
法学
经济
政治学
作者
Thomas Vanassche,Christelle Orlando,K. Vandenbosch,Alain Gadisseur,Cedric Hermans,Kristin Jochmans,Jean-Marc Minon,Serge Motte,Harlinde Peperstraete,Pierre Peters,Muriel Sprynger,Patrizio Lancellotti,Isabelle Dehaene,Patrick Emonts,Christophe Vandenbriele,Peter Verhamme,Cécile Oury
标识
DOI:10.1080/17843286.2020.1829252
摘要
COVID-19 predisposes patients to thrombotic disease. The aim of this guidance document is to provide Belgian health-care workers with recommendations on anticoagulation management in COVID-19 positive patients.These recommendations were based on current knowledge and a limited level of evidence.We formulated recommendations for the prophylaxis and treatment of COVID-related venous thromboembolism in ambulatory and hospitalised patients, as well as recommendations for the use of antithrombotic drugs in patients with prior indication for anticoagulation who develop COVID-19.These recommendations represent an easy-to-use practical guidance that can be implemented in every Belgian hospital and be used by primary care physicians and gynaecologists. Of note, they are likely to evolve with increased knowledge of the disease and availability of data from ongoing clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI